Overview

Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
To investigate safety, efficacy, and the dose-response relationship of DE-104 in lowering intraocular pressure in Japanese and Non-Japanese subjects with primary open-angle glaucoma or ocular hypertension.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Santen Inc.
Treatments:
Latanoprost
Ophthalmic Solutions